查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390611

荷尔蒙避孕市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Hormonal Contraceptive Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球荷尔蒙避孕药市场规模达到179亿美元。展望未来， IMARC Group预计到2028年市场规模将达到229亿美元，2022-2028年复合年增长率（CAGR）为4.19%。

荷尔蒙避孕药是孕激素或雌激素和黄体激素组合的製剂。它们作用于内分泌系统以阻止排卵和受精。因此，它们被用于预防意外怀孕，并且还可以缓解经期疼痛，并且通常会导致月经量减少。荷尔蒙避孕药被认为是最有效的方法之一，可以在阴道性交前后服用。它们包括避孕药、阴道环、避孕皮肤贴片和释放荷尔蒙的避孕线圈。荷尔蒙避孕药也会影响子宫内膜，使受精卵难以着床。

荷尔蒙避孕药市场趋势：

全球荷尔蒙避孕药市场主要是由大众计划生育意识的提高所推动的。这促进了防止意外怀孕的需要，特别是在年轻夫妇中。此外，与少女怀孕相关的健康问题显着增加，促进了避孕药具的使用，因为它们很容易获得。不同国家的政府也正在采取各种倡议，透过促进负担得起的高品质医疗保健服务来支持和改善这些产品的取得。除此之外，医疗保健产业的进步催生了荷尔蒙贴片、植入物、子宫内避孕器和药物器材组合产品等创新产品的生产。这些设备副作用较少，预防怀孕的效率提高，对市场的成长产生了有利的影响。

本报告回答的关键问题：

  • 迄今为止，全球荷尔蒙避孕药市场表现如何，未来几年将如何表现？
  • COVID-19 对全球荷尔蒙避孕药市场有何影响？
  • 主要区域市场有哪些？
  • 基于产品的市场区隔是什么？
  • 基于荷尔蒙的市场区隔是什么？
  • 市场按年龄层划分是怎样的？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球荷尔蒙避孕药市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球荷尔蒙避孕药市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 口服避孕药
    • 市场走向
    • 市场预测
  • 子宫内避孕器 (IUD)
    • 市场走向
    • 市场预测
  • 注射避孕药
    • 市场走向
    • 市场预测
  • 阴道环
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：荷尔蒙导致的市场分化

  • 仅含黄体素的避孕药
    • 市场走向
    • 市场预测
  • 复方荷尔蒙避孕药
    • 市场走向
    • 市场预测

第 8 章：按年龄组别分類的市场区隔

  • 15-24岁
    • 市场走向
    • 市场预测
  • 25-34岁
    • 市场走向
    • 市场预测
  • 35-44岁
    • 市场走向
    • 市场预测
  • 44岁以上
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 居家护理
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Afaxys Inc.
    • Agile Therapeutics Inc.
    • Allergan Inc. (AbbVie Inc.)
    • Bayer AG
    • Cipla Limited
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Pfizer Inc.
    • Piramal Group
    • Teva Pharmaceutical Industries Ltd
Product Code: SR112023A4403

Abstract

The global hormonal contraceptive market size reached US$ 17.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.9 Billion by 2028, exhibiting a growth rate (CAGR) of 4.19% during 2022-2028.

Hormonal contraceptives are formulations of progestin or a combination of estrogen and progesterone hormones. They act on the endocrine system to prevent ovulation and fertilization. As a result, they are used for preventing unwanted pregnancies and are also known to relieve period pain and often result in lighter periods. Hormonal contraceptives are considered one of the most effective methods, which can be taken before and after vaginal intercourse. They include birth control pills, vaginal rings, contraceptive skin patches, and hormone-releasing contraceptive coils. Hormonal contraceptives also affect the womb lining, making it hard for the fertilized eggs to be implanted.

Hormonal Contraceptive Market Trends:

The global hormonal contraceptive market is primarily driven by the increasing awareness among the masses regarding family planning. This has facilitated the need to prevent unintended pregnancies, especially among young couples. Furthermore, a significant rise in health issues associated with teenage pregnancies is promoting the use of contraceptives as they are easily accessible. Governments of different countries are also adopting various initiatives to support and improve access to these products by promoting affordable and high-quality healthcare services. Besides this, the advancements in the healthcare industry have resulted in the production of innovative products such as hormonal patches, implants, intrauterine devices, and drug-device combination products. These devices have fewer side effects and enhanced levels of efficiency in preventing pregnancy, which is favorably influencing the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hormonal contraceptive market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, hormone, age group and end user.

Breakup by Product:

Oral Contraceptive Pills

Intrauterine Device (IUD)

Injectable Birth Control

Vaginal Rings

Others

Breakup by Hormone:

Progestin-only Contraceptive

Combined Hormonal Contraceptive

Breakup by Age Group:

15-24 Years

25-34 Years

35-44 Years

Above 44 Years

Breakup by End User:

Hospitals and Clinics

Homecare

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Afaxys Inc., Agile Therapeutics Inc., Allergan Inc. (AbbVie Inc.), Bayer AG, Cipla Limited, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Piramal Group and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global hormonal contraceptive market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hormonal contraceptive market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the hormone?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hormonal contraceptive market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hormonal Contraceptive Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oral Contraceptive Pills
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intrauterine Device (IUD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Injectable Birth Control
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Vaginal Rings
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Hormone

  • 7.1 Progestin-only Contraceptive
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Combined Hormonal Contraceptive
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 15-24 Years
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 25-34 Years
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 35-44 Years
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Above 44 Years
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Homecare
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Afaxys Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agile Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Allergan Inc. (AbbVie Inc.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Bayer AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Cipla Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Pfizer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Piramal Group
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Teva Pharmaceutical Industries Ltd
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Hormonal Contraceptive Market: Major Drivers and Challenges
  • Figure 2: Global: Hormonal Contraceptive Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Hormonal Contraceptive Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Hormonal Contraceptive Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Hormonal Contraceptive Market: Breakup by Hormone (in %), 2022
  • Figure 6: Global: Hormonal Contraceptive Market: Breakup by Age Group (in %), 2022
  • Figure 7: Global: Hormonal Contraceptive Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Hormonal Contraceptive Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Hormonal Contraceptive (Injectable Birth Control) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Hormonal Contraceptive (Injectable Birth Control) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Hormonal Contraceptive (Vaginal Rings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Hormonal Contraceptive (Vaginal Rings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Hormonal Contraceptive (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Hormonal Contraceptive (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Hormonal Contraceptive (15-24 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Hormonal Contraceptive (15-24 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Hormonal Contraceptive (25-34 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Hormonal Contraceptive (25-34 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Hormonal Contraceptive (35-44 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Hormonal Contraceptive (35-44 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Hormonal Contraceptive (Above 44 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Hormonal Contraceptive (Above 44 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Hormonal Contraceptive (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Hormonal Contraceptive (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Hormonal Contraceptive (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Hormonal Contraceptive (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Hormonal Contraceptive (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Hormonal Contraceptive (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Hormonal Contraceptive Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Hormonal Contraceptive Industry: SWOT Analysis
  • Figure 89: Global: Hormonal Contraceptive Industry: Value Chain Analysis
  • Figure 90: Global: Hormonal Contraceptive Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hormonal Contraceptive Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Hormonal Contraceptive Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Hormonal Contraceptive Market Forecast: Breakup by Hormone (in Million US$), 2023-2028
  • Table 4: Global: Hormonal Contraceptive Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
  • Table 5: Global: Hormonal Contraceptive Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Hormonal Contraceptive Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Hormonal Contraceptive Market: Competitive Structure
  • Table 8: Global: Hormonal Contraceptive Market: Key Players